FDA clearance gets the device through the door, but the real value compounds from recurring consumable and service contract revenue on every unit in the field that hospitals and clinics reorder year after year without reconsidering their choice.
Rejigg lists 26 medical devices businesses for sale. The median asking price is $1.8M. 3 of them were listed in the last 30 days. The states with the most medical devices listings are California with 6 listings.
What to know about buying a medical devices business
How medical devices businesses are valued
Asking prices are set as a multiple of earnings: 3x–12x annual profit, depending on fda status, recurring revenue, and how much runs without you.
The wide range reflects how much value depends on your regulatory status, whether you have repeat revenue from consumables and service contracts, and how much of the business depends on the founder's technical expertise versus documented systems.
FDA clearance with a clean track record
Consumables and service contracts on installed units
Quality systems that are documented and current
Customers spread across different settings
What buyers of medical devices businesses look for
Device companies looking to add complementary products to their existing hospital sales relationships
Companies building medical device businesses by combining niche products and sharing distribution
First-time buyers with biomedical engineering or clinical backgrounds looking for a device business to own and operate
International device companies entering the U.S. market by acquiring an FDA-cleared, domestically manufactured product
The first questions buyers ask:
Claims & Status. Can this product legally be sold the way it’s being marketed?
FDA Pathway. What’s the FDA pathway story—past, present, and next?
QMS Reality. Show me the evidence your quality system is real (not a binder).
Closed deals
Rejigg medical devices deals closed
Across 42 closed deals on Rejigg, the median time from first pitch to close is 177.5 days.
Practical guidance from hundreds of real acquisition conversations.
FDA Clearance and Regulatory Files
Ask to see the clearance letters and confirm that device registrations are current.
Organized design records, complaint logs, and quality documentation mean the hard regulatory work is already done — and gaps in those files are what slow most device deals.
Gaps in regulatory files are one of the most common things that slow or complicate device acquisitions.
Finding a business where all of that is current and organized is something to get genuinely excited about.
Installed Base Revenue
Ask how many units are installed in the field and what the average annual consumable spend per unit looks like.
High consumable usage across a large installed base is the most reliable signal that revenue will carry through an ownership change.
Ask about the service contract attachment rate and how that revenue is structured.
Businesses where recurring revenue from installed units represents a large share of total revenue are fundamentally more predictable than those relying on capital equipment sales.
Customer Diversity and Settings
Revenue spread across hospitals, outpatient clinics, labs, and specialty practices proves the device is clinically useful in multiple settings.
Ask for a breakdown of revenue by customer category and confirm no single account makes up too large a share.
Understanding which customer types drive consumable usage versus one-time capital purchases helps you see where recurring revenue actually lives.
Diverse settings also reduce dependence on any one reimbursement environment.
Quality Systems and Team Independence
Ask who runs production and field service, how long they have been in the role, and whether the quality system operates without the founder's daily involvement.
Written procedures, calibration records, and complaint handling that would hold up to a review show the business runs on systems, not the founder's technical knowledge.
A clean quality record with no open observations is worth asking about specifically — it's one of the most telling signals that the system runs independently.
Documented systems that work independently are a meaningful premium driver in any device acquisition.
Valuation
What Should You Expect to Pay?
3x-6x
SDE
FDA-cleared, early installed base or founder-dependent
7x-12x
EBITDA
With large installed base, recurring revenue, and quality systems
Medical device multiples vary more than most industries because FDA clearance, consumable revenue as a share of total revenue, and the quality of the regulatory documentation all shift the valuation significantly. A cleared device with a large installed base generating predictable consumable orders can command a much higher multiple than a cleared device relying primarily on capital equipment sales.
What drives a premium
Current FDA clearance with organized design records, complaint logs, and quality system documentation
Installed base generating recurring consumable or service contract revenue at high margins
Customer revenue spread across hospitals, labs, clinics, and specialty practices with no dominant account
Engineering and quality team that runs production and field service without founder involvement
How do I contact the owner of a business I found on Rejigg?
Create a free Rejigg account; owners, and the brokers who run some sales, only hear from buyers through the platform. Open the listing to see the full profile: city, team size, financials, what is for sale, and the reason for selling. Sign Rejigg's standard Fee & Confidentiality Agreement for that business; it is the same form for every deal. Verify your phone, then send your pitch from the listing. Replies, meetings, and documents all run through Rejigg.
Can I email Rejigg to get introduced to an owner?
No. Rejigg does not forward emails to owners or brokers, so a note to support@ or hello@ with a listing link will not reach them. Create a free account, open the listing, sign the agreement for that business, verify your phone, and send your pitch; that reaches them in a few minutes.
Can this product legally be sold the way it’s being marketed?
Buyers are sizing up stop-ship risk. They want proof that your website, labeling, sales decks, distributor listings, and rep scripts stay inside your cleared or registered use, or that you have a defensible reason for how you sell today. If you can’t show that line clearly, they assume enforcement risk and product liability exposure, even if nothing has happened yet.
What’s the FDA pathway story—past, present, and next?
They are underwriting regulatory timeline risk and whether your growth plan triggers a new submission, a new test, or a pause in sales. This gets pointed with RUO (Research Use Only) products because the buyer will test whether revenue is being driven by clinical use while the company looks away. They also want a clean narrative on inspections, significant quality events, and what changed afterward.
Show me the evidence your quality system is real (not a binder).
Buyers are looking for proof that quality work happens when nobody is watching. They want to see complaint handling, investigations, corrective actions, training, audits, and management review operating as a routine, not a scramble right before an audit. A spotless log often reads like under-reporting, so be ready to explain your thresholds and your process.
Make design history and change history easy to understand—what’s changed, why, and was it controlled?
In medical devices, uncontrolled change is where diligence bogs down because it can break prior testing assumptions, labeling support, and manufacturing readiness. Buyers want confidence they can maintain and improve the device without discovering undocumented design drift. A clear change summary usually speeds diligence up because the buyer doesn’t have to reconstruct your history from raw files.
How do you handle labeling, UDI (Unique Device Identifier), and anything customer-facing that can trigger a recall?
They want to see traceability and revision control because labeling errors and identifier mismatches can turn into costly field actions, even when the device performs fine. UDI touches packaging, systems, and customer requirements, so gaps here can become liabilities on day one after close. Buyers look for proof you can identify affected lots, versions, and customers quickly and reliably.
Walk me through manufacturing step by step, including your “no one talks about it” controls.
Buyers are judging whether you can consistently stop bad product from shipping and whether your output is transferable to a new owner. They will dig into incoming inspection, calibration, acceptance criteria, rework rules, and what you do when yield drops. If production depends on tribal knowledge or a contract manufacturer’s undocumented process, they will price in disruption risk.